These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18069309)

  • 21. A case of hypocomplementaemic urticarial vasculitis with cardiac valve involvement successfully treated with cyclophosphamide and high-dose glucocorticoids.
    Hauser B; McRorie E; McKay N; Brenn T; Amft N
    Int J Rheum Dis; 2017 Nov; 20(11):1850-1852. PubMed ID: 24702778
    [No Abstract]   [Full Text] [Related]  

  • 22. Posterior reversible encephalopathy syndrome secondary to eclampsia.
    Amagada JO; Kondagunta H; Afshan N; Watermeyer S; Jones R
    J Obstet Gynaecol; 2008 Aug; 28(6):646-7. PubMed ID: 19003669
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed posterior reversible encephalopathy syndrome (PRES) after posterior fossa surgery.
    Avecillas-Chasín JM; Gómez G; Jorquera M; Alvarado LR; Barcia JA
    Acta Neurochir (Wien); 2013 Jun; 155(6):1045-7. PubMed ID: 23588274
    [No Abstract]   [Full Text] [Related]  

  • 24. Basiliximab for posterior reversible encephalopathy syndrome after lung transplantation.
    Yamagishi H; Chen-Yoshikawa TF; Date H
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):823-824. PubMed ID: 28498905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational therapy in systemic necrotising vasculitis.
    Carruthers DM
    Clin Med (Lond); 2001; 1(1):7-9. PubMed ID: 11358081
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.
    Zhang YX; Liu JR; Ding MP; Huang J; Zhang M; Jansen O; Deuschl G; Eschenfelder CC
    Intern Med; 2008; 47(9):867-75. PubMed ID: 18451582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fulminant neurologic presentation of systemic lupus erythematosus.
    Bhavsar SV; White CM; Fifi-Mah A
    Int J Rheum Dis; 2012 Apr; 15(2):e34-6. PubMed ID: 22462433
    [No Abstract]   [Full Text] [Related]  

  • 28. Post renal transplant posterior reversible encephalopathy syndrome.
    Kulkarni RN; Saxen SK; Hartalkar A
    J Assoc Physicians India; 2013 Oct; 61(10):743-5. PubMed ID: 24772733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Hebert LA; Rovin BH
    Ann Intern Med; 2010 Jan; 152(1):64; author reply 65. PubMed ID: 20048278
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk of malignancy in patients treated for systemic necrotising vasculitis.
    Lafarge A; Joseph A; Pagnoux C; Puechal X; Cohen P; Samson M; Hamidou M; Karras A; Groh M; Quemeneur T; Ribi C; Mouthon L; Guillevin L; Terrier B;
    Ann Rheum Dis; 2020 Mar; 79(3):431-433. PubMed ID: 31767700
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Levine SM
    Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversible posterior leukoencephalopathy syndrome of bilateral thalamus in acute lymphoblastic leukemia.
    Kamezaki M; Kakimoto T; Takeuchi T; Akuta K; Kasahara H; Yamamoto K; Ujiie H; Sugahara H; Nishinaka K; Udaka F; Sakoda H
    Leuk Lymphoma; 2012 Oct; 53(10):2083-4. PubMed ID: 22397315
    [No Abstract]   [Full Text] [Related]  

  • 33. Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome.
    Vitucci A; Lojacono A; Gatti E; Prefumo F; Fratelli N
    J Obstet Gynaecol; 2019 Apr; 39(3):412-414. PubMed ID: 30226402
    [No Abstract]   [Full Text] [Related]  

  • 34. Posterior reversible encephalopathy syndrome (PRES).
    Rowley C; Onslow J
    Int J Obstet Anesth; 2008 Apr; 17(2):195-6. PubMed ID: 18313287
    [No Abstract]   [Full Text] [Related]  

  • 35. Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES).
    Kunzmann J; Wolf H; Oberndorfer S
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26611477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible posterior leukoencephalopathy syndrome.
    Moon JM; Chun BJ
    J Emerg Med; 2010 Apr; 38(3):e1-4. PubMed ID: 18024064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Padhan P
    Ann Intern Med; 2010 Jan; 152(1):64; author reply 65. PubMed ID: 20048279
    [No Abstract]   [Full Text] [Related]  

  • 38. Posterior reversible leukoencephalopathy.
    Hashmi M; Siddiqi SA; Saleem F; Mustafa MS
    J Pak Med Assoc; 2007 Sep; 57(9):468-70. PubMed ID: 18072644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
    de Groot K; Harper L; Jayne DR; Flores Suarez LF; Gregorini G; Gross WL; Luqmani R; Pusey CD; Rasmussen N; Sinico RA; Tesar V; Vanhille P; Westman K; Savage CO;
    Ann Intern Med; 2009 May; 150(10):670-80. PubMed ID: 19451574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report.
    Jayaweera JL; Withana MR; Dalpatadu CK; Beligaswatta CD; Rajapakse T; Jayasinghe S; Chang T
    J Med Case Rep; 2014 Dec; 8():442. PubMed ID: 25519913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.